Javascript must be enabled to continue!
Carrier Detection in Classical Hemophilia
View through CrossRef
Rabbit antibody to purified human factor VIII was prepared and absorbed until it formed only one precipitin line against normal and hemophilic plasmas and no line against severe von Willebrand's disease plasma. The plasma protein which combines with this rabbit antibody to factor VIII is referred to as factor VIII antigen. The ratio of percent factor VIII activity (by coagulation assay) to percent factor VIII antigen was used for carrier detection. Thirty-seven normal women, 33 obligate carriers, 12 probable carriers, and 39 possible carriers, were studied by this technique. Using the ratio of 0.84 as the division between normals and carriers, 31 of the 33 carriers (91%) were classified as carriers. Twenty of the 39 possible carriers were classified as carriers (51%) and ten of the 12 probable carriers were positively identified. The results of discriminate analysis of all three variables (VIII activity, VIII antigen, and the ratio of VIII activity to VIII antigen indicated that the discrimination power of the ratio alone could not be improved by introducing the other variables on this set of data. These findings confirm the usefulness of the VIII activity to VIII antigen ratio in the detection of carriers of classical hemophilia.
American Academy of Pediatrics (AAP)
Title: Carrier Detection in Classical Hemophilia
Description:
Rabbit antibody to purified human factor VIII was prepared and absorbed until it formed only one precipitin line against normal and hemophilic plasmas and no line against severe von Willebrand's disease plasma.
The plasma protein which combines with this rabbit antibody to factor VIII is referred to as factor VIII antigen.
The ratio of percent factor VIII activity (by coagulation assay) to percent factor VIII antigen was used for carrier detection.
Thirty-seven normal women, 33 obligate carriers, 12 probable carriers, and 39 possible carriers, were studied by this technique.
Using the ratio of 0.
84 as the division between normals and carriers, 31 of the 33 carriers (91%) were classified as carriers.
Twenty of the 39 possible carriers were classified as carriers (51%) and ten of the 12 probable carriers were positively identified.
The results of discriminate analysis of all three variables (VIII activity, VIII antigen, and the ratio of VIII activity to VIII antigen indicated that the discrimination power of the ratio alone could not be improved by introducing the other variables on this set of data.
These findings confirm the usefulness of the VIII activity to VIII antigen ratio in the detection of carriers of classical hemophilia.
Related Results
Hemophilia
Hemophilia
Hemophilia is a family of rare bleeding disorders characterized by deficiency of clotting factors. Hemophilia A is an inherited deficiency of factor VIII, whereas hemophilia B (Chris...
Antithrombotic Therapy in People with Hemophilia—A Narrative Review
Antithrombotic Therapy in People with Hemophilia—A Narrative Review
As the life expectancy of individuals with hemophilia continues to increase, the complexity of balancing bleeding risks and thrombotic management has become increasingly critical i...
A Systematic Review of the Oral Health Status of Hemophilic Patients
A Systematic Review of the Oral Health Status of Hemophilic Patients
Background: Hemophilia is an inherited bleeding disorder, with the most well-known forms being hemophilia A and hemophilia B. It is important for patients with hemophilia to mainta...
CRISPR/Cas9-mediated knockin of human factor IX into swine factor IX locus effectively alleviates bleeding in hemophilia B pigs
CRISPR/Cas9-mediated knockin of human factor IX into swine factor IX locus effectively alleviates bleeding in hemophilia B pigs
Hemophilia B is an X-linked recessive bleeding disorder caused by abnormalities in the coagulation factor IX gene. Without prophylactic treatment, patients experience frequent spon...
Health-Related Quality of Life Assessment in Iranian Hemophilia Patients (Single Center); A Cross-Sectional Study
Health-Related Quality of Life Assessment in Iranian Hemophilia Patients (Single Center); A Cross-Sectional Study
Abstract
Background: Hemophilia affects the patients′ life in many aspects. The major concerns are restriction on physical activities, life-threatening bleeding, arthropath...
Frequency of Inhibitors among known Hemophilia A Patients.
Frequency of Inhibitors among known Hemophilia A Patients.
ABSTRACT
Introduction: Inhibitors are IgG alloantibodies which are directed against exogenous clotting factor VIII that neutralize the function of infused clotting factor con...
Haemophilia Care in Martinique: From 1982 to 2015
Haemophilia Care in Martinique: From 1982 to 2015
Abstract
Introduction: Hemophilia A (HA) and B (HB) are the most common congenital bleeding disorders, characterised by missing clotting factor VIII (FVIII) for HA o...
Genetic Carrier Testing
Genetic Carrier Testing
Abstract
Genetic carrier testing includes tests for the heterozygous status of a recessively inherited disorder in individuals wh...


